A taste of its own medicine?

Teva Pharmaceuticals, Israel’s biggest company, has seen its share price halved as generics eat at its profits, and leveraged buyouts have left it burdened with huge debts.

February 21, 2017 16:48
Erez Vigodman

Erez Vigodman. (photo credit: WWW.TEVAPHARM.COM)

TEVA PHARMACEUTICAL Industries is in trouble. By definition, when the share price of Israel’s oldest and biggest global company plunges 50 percent in one year, it is time to worry and investigate.

Teva’s stock-price chart looks like the Himalayas or the Kingda Ka roller coaster in Jackson, New Jersey, the world’s tallest.


Related Content